HSP90AA1 and breast carcinoma: In order to explore the specificity of the antibodies, western blot analysis was performed in MDA-MB-453 breast cancer cell lysates using a commercial polyclonal anti-HSP90α antibody (Chemicon International, USA), mAb 4C5, rec-4C5 and ch-4C5.